The advantages of the treatment of the patients with type 2 diabetes mellitus with gliclazide MR | Zendy

Елена Владимировна Пекарева | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The advantages of the treatment of the patients with type 2 diabetes mellitus with gliclazide MR

Author(s) -

Елена Владимировна Пекарева

Publication year - 2012

Publication title -

problems of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.124

H-Index - 5

eISSN - 2308-1430

pISSN - 0375-9660

DOI - 10.14341/probl201258258-61

Subject(s) - gliclazide , medicine , diabetes mellitus , type 2 diabetes mellitus , endocrinology , insulin , type 2 diabetes

Type 2 diabetes mellitus (DM2) is a chronic condition characterized by progressive hyperglycemia resulting from beta-cell dysfunction and impaired insulin secretion. The maintenance of the target blood glucose level not only promotes preservation of the beta-cell pool but also reduces the risk of the development and progression of vascular complications of diabetes. This paper is designed to report the results of comparative investigations of the application of sulphonylurea derivatives for the treatment of the patients with type 2 diabetes mellitus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research